Stockreport

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for [Read more]